X4 Pharmaceuticals, Inc.

XFOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $26.7M
Accounts Receivable —
Inventory —
Total Current Assets $79.5M
Property, Plant & Equipment $421.0K
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $81.3M
Liabilities
Accounts Payable $1.9M
Total Current Liabilities $10.7M
Long-Term Debt —
Total Liabilities $22.5M
Stockholders' Equity
Retained Earnings $-92.3M
Total Stockholders' Equity $-44.5M
← Newer Page 2 of 2 Older →